speb/financial-data huggingface dataset:
Financial scorecard for LSEG.L (Financial Services — Financial Data & Stock Exchanges, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 1.1698666666666666
Market cap: 42721480704 (USD: 57731730681.081085)
P/E ratio: 0.5047325806819477
P/B ratio: 0.019443011857398
Debt to equity: 0.5297
Current ratio: 1
Interest coverage ratio: 6.697530864197532
Return on net tangible assets (%): -31.49469288324343
Buffett classification: The Great
Analyst consensus upside (%): 1009472.5033890647
Rule of 40 score: 30.541577250202593
Altman Z-score: 0.05635484131142252 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 1.6806533579084812
Buyback yield (%): 5.037278588048818
Debt paydown yield (%): -5.852734874345988
Total shareholder yield (%): 0.8651970716113109 (Low Return)
Momentum (%): 1m 7.379066022544295, 3m -13.360555110755273, 6m -0.14978854286812499, 12m -14.10841022588221, composite -11.173735071901346 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 4, short score 4, recommendation: Neutral
Revenue growth 1y (%): 14.063939758227416
Net income growth 1y (%): 76.77612465886081
Revenue CAGR 3y (%): 10.62525803112473
Net income CAGR 3y (%): 4.247240334525726
FCF CAGR 3y (%): 2.813078902582844
Revenue deceleration: no
Revenue growth consistency score: 5.478315321766962
Beneish M-score: -2.459811235260026 (Likely Safe)
Equity multiplier (leverage): 35.42756347894784
ROE archetype: Standard Business
P/E z-score: 4.619626988045038
FCF z-score: 4.619626988045034
Treasury beta 1y: 0.002848679189490007 (R-squared: 0.0011965733754302711)
Insider 90-day net shares: 8234542 (net value USD: 1038334198.00)
Dividend increase streak (years): 0
ROIC (%): 5.354850480889003 (pretax: 7.001129214389406)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 13.953488372093023, P/B 0, ROIC 58.139534883720934, revenue growth 1y 25.581395348837212, 6m momentum 27.906976744186046
Sector percentiles: P/E 13.088463528194517, 6m momentum 40.84324883600621
Industry median P/E: 19.132963988919666; industry median ROIC: 11.257628306763747
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.055585448906648335
Base cash flow: 4891891891.8918915
DCF price per share: base 8.790757750582834, conservative 4.853965601035645, aggressive 16.131074228221784
Financial scorecard for LSTA (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.67
Market cap: 15207673 (USD: 15207673)
P/B ratio: 4.275020512556222
Debt to equity: 0
Current ratio: 4.23
Return on net tangible assets (%): -41.067179205564706
Buffett classification: The Gruesome
Rule of 40 score: -100
Altman Z-score: -54.22753730048572 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -51.45348837209303, 3m -47.81250000000001, 6m -59.36739659367397, 12m -37.21804511278196, composite -25.95219610766577 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.08841933150960601
FCF conversion rate: 0.6867899309423035
Beneish M-score: -3.647099837231201 (Likely Safe)
ROE (%): -35.52407707830491
Asset turnover: 0
Equity multiplier (leverage): 1.258378506706762
ROE archetype: Low Return
Treasury beta 1y: 0.0010270769359760207 (R-squared: 1.4851364322399942e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
Incremental ROIC 3y (%): 2505.6103059581324 (pretax: 3171.658615136876)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 42.418772563176894, ROIC , revenue growth 1y , 6m momentum 70.12635379061372
Sector percentiles: P/E , 6m momentum 73.67478510028653
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09090000000000001
Base cash flow: -16468000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for LSTR (Industrials — Integrated Freight & Logistics, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 200.28
Market cap: 6795141632 (USD: 6795141632)
P/E ratio: 44.0633608815427
P/B ratio: 6.792215522744112
Debt to equity: 0.1555
Current ratio: 1.88
Return on net tangible assets (%): 5.929505824403801
Buffett classification: The Great
Analyst consensus upside (%): 23.83244763988747
Rule of 40 score: 5.698037410167449
Altman Z-score: 8.839818069844055 (Safe Zone)
Piotroski F-score: 9 (Strong)
Magic formula: return on capital % 6.215782711017178, earnings yield % 0.7722587825309042, rank 1312
Dividend yield (%): 1.2027858200204178
Buyback yield (%): 0.32945597328794574
Debt paydown yield (%): 0.14389692709204152
Total shareholder yield (%): 1.676138720400405 (Low Return)
Momentum (%): 1m -3.5631741140215745, 3m 12.1263016459523, 6m 30.75667558921461, 12m 45.700567437800075, composite 31.32230964340182 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 8, short score 1, recommendation: Long
Revenue growth 1y (%): 1.6302791665437466
Net income growth 1y (%): 32.32235120445548
Revenue deceleration: no
Accrual ratio: -0.020355556735933946
FCF conversion rate: 1.8356237322515212
Beneish M-score: -2.5112694588403075 (Likely Safe)
ROE (%): 4.946567910896559
Net margin (%): 3.3672247118777485
Asset turnover: 0.7234360046360048
Equity multiplier (leverage): 2.0306344813660253
ROE archetype: Low Return
P/E z-score: 4.253788964296874
FCF z-score: 4.253788964296874
Treasury beta 1y: -0.0039084616097350856 (R-squared: 0.0024056354152074857)
Insider 90-day net shares: -12446 (net value USD: -2750328.00)
Dividend increase streak (years): 0
ROIC (%): 27.23450507733254 (pretax: 35.65869041927719)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 67.53246753246754, P/B 74.67532467532467, ROIC 5.844155844155844, revenue growth 1y 28.57142857142857, 6m momentum 9.740259740259742
Sector percentiles: P/E 62.80081925243216, 6m momentum 12.135176651305683
Industry median P/E: 1.6524312026398307; industry median ROIC: 5.860649403527186
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.09410077302150062
Base cash flow: 158440000
DCF price per share: base 76.14992389678461, conservative 69.16154070876303, aggressive 84.43221891840341
Financial scorecard for LSTR.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2025-12-31 (annual)
Stock price: 0.0425531914893617
Market cap: 3348686 (USD: 2444296.3503649635)
P/B ratio: 4.696353638703938
Debt to equity: 0
Current ratio: 11.48
Interest coverage ratio: -730.4370664023787
Return on net tangible assets (%): -147.47045839623308
Buffett classification: The Gruesome
Analyst consensus upside (%): 329.2666666666667
Rule of 40 score: 0
Altman Z-score: 2.78478986665265 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560277, 3m -51.41843971631205, 6m -69.09294512877939, 12m -3.546099290780135, composite -41.57891231925583 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -1.0466380089902945
FCF conversion rate: 0.09760426291105388
Beneish M-score: -3.0064209944725167 (Likely Safe)
ROE (%): -121.77234877493098
Asset turnover: 0
Equity multiplier (leverage): 1.0499030943450578
ROE archetype: Low Return
Treasury beta 1y: -0.016841303364594398 (R-squared: 0.001819357176865939)
Insider 90-day net shares: -3403500 (net value USD: -133408.00)
Dividend increase streak (years): 0
ROIC (%): -229.00603745978313 (pretax: -289.88106007567484)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 43.21398834304746, ROIC 54.70441298917569, revenue growth 1y , 6m momentum 78.51790174854288
Sector percentiles: P/E , 6m momentum 81.73237090505275
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.0722
Base cash flow: -1771234.306569343
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for LSX.AX (Basic Materials — Gold, Australia)
Report date: 2025-07-31 (annual)
Stock price: 0.5902777777777778
Market cap: 121759088 (USD: 78554250.32258064)
P/E ratio: 1.3752122241086588
P/B ratio: 0.9098691196882132
Debt to equity: 0.0005
Current ratio: 11.71
Return on net tangible assets (%): 30.788171545525124
Buffett classification: The Gruesome
Rule of 40 score: 1038.5362677400578
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 1.8931878306878245, 3m -10.175120772946872, 6m -20.203189300411527, 12m 3.6417958656330733, composite -9.55406379617159 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 6, short score 0, recommendation: Neutral
Revenue growth 1y (%): 1036.75893201388
Net income growth 1y (%): 3393.0028848675584
Revenue CAGR 3y (%): 72.40083852492536
Net income CAGR 3y (%): 58.763906510543066
Revenue deceleration: no
Revenue growth consistency score: 611.1076106085901
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 1.043396093253766
ROE archetype: Standard Business
P/E z-score: 4.875672442853098
FCF z-score: 3.369116021741903
Treasury beta 1y: 0.004867049890436878 (R-squared: 0.0017097675396320797)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 3.5410764872521248, P/B 8.78186968838527, ROIC , revenue growth 1y 0.28328611898017, 6m momentum 27.47875354107649
Sector percentiles: P/E 18.267629094947253, 6m momentum 44.39200444197668
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07988682878342936
Base cash flow: 25330322.580645163
DCF price per share: base 5.394615378978371, conservative 2.965820876244055, aggressive 9.886569009615512
Financial scorecard for M7T.AX (Healthcare — Health Information Services, United States)
Report date: 2024-06-30 (annual)
Stock price: 0.2013888888888889
Market cap: 69327864 (USD: 69327864)
P/B ratio: 1.8760012119913807
Debt to equity: 0.0253
Current ratio: 2.15
Return on net tangible assets (%): -3.0487315323198785
Buffett classification: The Gruesome
Analyst consensus upside (%): 45.312499999999986
Rule of 40 score: 2.8629498138223965
Altman Z-score: 0.1781354456666633 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.09754375239369845
Total shareholder yield (%): -0.09754375239369845 (Minimal or Negative)
Momentum (%): 1m -5.801971326164876, 3m 0.6944444444444279, 6m -34.660493827160494, 12m -27.595899470899464, composite -19.03411279369134 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 4, short score 12, recommendation: Short
Revenue growth 1y (%): -14.876246133964322
Revenue CAGR 3y (%): -3.225841107483618
FCF CAGR 3y (%): 29.87232713831265
Revenue deceleration: yes
Revenue growth consistency score: 11.877778141036144
Accrual ratio: -0.13916482155328133
FCF conversion rate: -0.3838032180373094
Beneish M-score: -3.0066684658803178 (Likely Safe)
ROE (%): -13.920614782016052
Net margin (%): -46.21950810756959
Asset turnover: 0.21758543048782547
Equity multiplier (leverage): 1.3842141510623267
ROE archetype: Low Return
FCF z-score: 4.71447153159158
Treasury beta 1y: 0.009372744362733486 (R-squared: 0.003143646552736173)
Insider 90-day net shares: 739019 (net value USD: 146215.00)
Dividend increase streak (years): 0
ROIC (%): -61.82962401712726 (pretax: -78.26534685712312)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 23.684210526315788, ROIC 51.578947368421055, revenue growth 1y 40, 6m momentum 63.1578947368421
Sector percentiles: P/E , 6m momentum 61.10315186246418
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09939846467216297
Base cash flow: -866542
DCF price per share: base 0.05699320058330796, conservative 0.061880145049188116, aggressive 0.05125771389626842
Financial scorecard for MA (Financial Services — Credit Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 539.66
Market cap: 476834856960 (USD: 476834856960)
P/E ratio: 28.834394904458602
P/B ratio: 64.97139712185361
Debt to equity: 2.8206
Current ratio: 0.98
Interest coverage ratio: 26.83783783783784
Return on net tangible assets (%): -48.51222744247681
Buffett classification: The Great
Analyst consensus upside (%): 29.37325541699299
Rule of 40 score: 25.469200701398847
Altman Z-score: 9.072094190353383 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0.16294949680349813
Buyback yield (%): 0.8462049158328377
Debt paydown yield (%): 0.008388648484092567
Total shareholder yield (%): 1.0175430611204284 (Low Return)
Momentum (%): 1m 9.335872604238418, 3m 7.2179285955536105, 6m 3.1933608689000934, 12m -3.6338636810057, composite -0.4836662363239241 (Moderate Downtrend)
Lynch category: Stalwart (confidence: High)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue growth 1y (%): 15.834482758620695
Net income growth 1y (%): 18.35365853658537
Revenue deceleration: no
Accrual ratio: 0.02285049621972497
FCF conversion rate: 0.6862442040185471
Beneish M-score: -2.208914010835744 (Likely Safe)
ROE (%): 53.66325684268731
Net margin (%): 46.22529173612765
Asset turnover: 0.15755210776128922
Equity multiplier (leverage): 7.368399225877799
ROE archetype: Leverage-Driven Returns
P/E z-score: 4.780092050202132
FCF z-score: 4.780092050202126
Treasury beta 1y: -0.003137436448873249 (R-squared: 0.0038744582283601198)
Insider 90-day net shares: -41609 (net value USD: -22063270.00)
Dividend increase streak (years): 0
ROIC (%): 99.20570644505295 (pretax: 123.13225643614336)
Incremental ROIC 3y (%): 173.46573484154254 (pretax: 237.81512605042016)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 64.22764227642277, P/B 76.82926829268293, ROIC 0.8130081300813009, revenue growth 1y 21.138211382113823, 6m momentum 25.203252032520325
Sector percentiles: P/E 50.517330574236944, 6m momentum 31.66063114330057
Industry median P/E: 1.1381675934474376; industry median ROIC: 3.60918150844996
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.08497696745598518
Base cash flow: 15622000000
DCF price per share: base 716.2726144494576, conservative 396.47982175358305, aggressive 1298.1319238680078
Financial scorecard for MAANALU.NS (Basic Materials — Aluminum, India)
Report date: 2026-03-31 (annual)
Stock price: 1.185590421139554
Market cap: 6889861632 (USD: 73016761.67867741)
P/E ratio: 0.5427574719507213
P/B ratio: 2.627638296579025
Debt to equity: 0.19940000000000002
Current ratio: 3.03
Interest coverage ratio: 2.343866171003717
Return on net tangible assets (%): -1.2952422650321083
Buffett classification: The Gruesome
Rule of 40 score: -10.332842869617318
Altman Z-score: 7.511304329654768 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 4.641319150502412, earnings yield % 0.019619707117134913, rank 6194
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 6.482911994147764
Total shareholder yield (%): 6.482911994147764 (Moderate Return)
Momentum (%): 1m -12.237909251778852, 3m -22.971408675565456, 6m -23.398024868013856, 12m -14.921086057759583, composite -16.475587877070613 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 6, short score 4, recommendation: Neutral
Revenue growth 1y (%): -6.135653906435367
Net income growth 1y (%): -60.88583952160749
Revenue deceleration: no
Revenue growth consistency score: 10.011420379219853
Beneish M-score: 5.948611888961733 (Strong Manipulation Signal)
ROE (%): 0.6187443130118289
Net margin (%): 0.6677927485563893
Asset turnover: 0.7010437033569245
Equity multiplier (leverage): 1.3216742493175615
ROE archetype: Low Return
P/E z-score: 4.629644197858372
Treasury beta 1y: 0.00040846950513417115 (R-squared: 1.5215144517530395e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 3.339350906875553 (pretax: 4.546437842515143)
Incremental ROIC 3y (%): -72.56823052668662 (pretax: -97.06512996045815)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 25, P/B 55.55555555555556, ROIC 69.44444444444444, revenue growth 1y 58.333333333333336, 6m momentum 61.111111111111114
Sector percentiles: P/E 15.741254858411994, 6m momentum 47.83453636868407
Industry median P/E: 1.2289943900616713; industry median ROIC: 8.064171582371397
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.080442987982829
Base cash flow: -376218.73675286165
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MAC (Real Estate — REIT - Retail, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 25.83
Market cap: 7982254592 (USD: 7982254592)
P/B ratio: 2.223522062383105
Debt to equity: 1.9897
Current ratio: 0.3
Interest coverage ratio: 0.45912592592592594
Buffett classification: The Great
Analyst consensus upside (%): 39.53116675546085
Rule of 40 score: 21.88637888037142
Altman Z-score: 0.18446246482111317 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0.6142875980069967
Buyback yield (%): 0
Debt paydown yield (%): 1.730814250631208
Total shareholder yield (%): 2.3451018486382047 (Low Return)
Momentum (%): 1m 1.6528925619834638, 3m 22.64957264957265, 6m 43.02325581395349, 12m 51.49560117302051, composite 38.235028842680755 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 4, recommendation: Neutral
Revenue growth 1y (%): -3.083972651109046
Revenue deceleration: no
Accrual ratio: -0.013734823950672168
FCF conversion rate: -2.128665749656121
Beneish M-score: -2.5603139359961715 (Likely Safe)
ROE (%): -1.4427649011616739
Net margin (%): -15.049391814124485
Asset turnover: 0.02917057433500799
Equity multiplier (leverage): 3.2864848849042736
ROE archetype: Low Return
FCF z-score: 4.850148919359237
Treasury beta 1y: -0.003882233882382212 (R-squared: 0.0030028313793118732)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 1.795146902596851 (pretax: 2.272337851388419)
Incremental ROIC 3y (%): 39.900672441303854 (pretax: 50.50718030544792)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 76.27118644067797, ROIC 88.13559322033898, revenue growth 1y 64.40677966101694, 6m momentum 3.389830508474576
Sector percentiles: P/E , 6m momentum 3.7267080745341614
Industry median P/E: 13.362381989832972; industry median ROIC: 3.8218423418177516
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.1034039338880567
Base cash flow: 170954000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MAD.AX (Industrials — Specialty Business Services, Australia)
Report date: 2025-06-30 (annual)
Stock price: 5.090277777777778
Market cap: 1491374464 (USD: 974754551.633987)
P/E ratio: 15.077755240027049
P/B ratio: 6.411216483144852
Debt to equity: 0.12539999999999998
Current ratio: 1.9
Interest coverage ratio: 13.981519507186858
Return on net tangible assets (%): 22.86761277195032
Buffett classification: The Good
Analyst consensus upside (%): 116.80717488789236
Rule of 40 score: 15.301430471235474
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 23.923650912859973, earnings yield % 2.386266553460639, rank 2051
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -5.615053992611549, 3m -8.753023189642906, 6m -11.945431806213799, 12m 8.717389596102462, composite -1.8377867105634926 (Moderate Uptrend)
Lynch category: Fast Grower (confidence: High)
Screener: long score 11, short score 0, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 10.410705616213356
Net income growth 1y (%): 11.12174098699954
Revenue CAGR 3y (%): 27.152709588221114
Net income CAGR 3y (%): 24.677656744457455
Revenue deceleration: yes
Revenue growth consistency score: 17.491462272141103
Accrual ratio: 0.041897266687668314
FCF conversion rate: 0.746443382854743
Beneish M-score: -1.3001896089903167 (Strong Manipulation Signal)
Equity multiplier (leverage): 1.6343537014445928
ROE archetype: Standard Business
P/E z-score: 4.595273458443605
FCF z-score: 3.2043541683809718
Treasury beta 1y: 0.012869807004818769 (R-squared: 0.02131115916454131)
Insider 90-day net shares: -9724 (net value USD: -58820.00)
Dividend increase streak (years): 3
ROIC (%): 17.091507802043168 (pretax: 23.95658331061053)
Incremental ROIC 3y (%): 19.66451007921449 (pretax: 26.732570849035735)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 54.137931034482754, P/B 69.6551724137931, ROIC 20.689655172413794, revenue growth 1y 15.517241379310345, 6m momentum 59.6551724137931
Sector percentiles: P/E 50.89605734767025, 6m momentum 59.80542754736303
Industry median P/E: 0.2625461273512518; industry median ROIC: 8.492361488286793
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10137078428501273
Base cash flow: 31732026.14379085
DCF price per share: base 3.0836111480236705, conservative 1.7664390406185437, aggressive 5.40997357600637
Financial scorecard for MADHAV.NS (Industrials — Building Products & Equipment, India)
Report date: 2026-03-31 (annual)
Stock price: 0.34878199834847234
Market cap: 302319136 (USD: 3203890.8011869434)
P/E ratio: 0.7419094937558749
P/B ratio: 0.2333983488018412
Debt to equity: 0.0674
Current ratio: 4.07
Interest coverage ratio: -3.4588516746411484
Return on net tangible assets (%): -0.27496093478573547
Buffett classification: The Gruesome
Rule of 40 score: 4.845653031281662
Altman Z-score: 1.3707084840292418 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -7.96487218517439, 3m -15.598164400682101, 6m -12.985068749901568, 12m -31.91422354878443, composite -18.2017336643005 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 8, recommendation: Short
Revenue growth 1y (%): 9.17664179865374
Net income growth 1y (%): 7493.956089754278
Revenue deceleration: no
Revenue growth consistency score: 12.074020407603763
Accrual ratio: -0.029456702500444056
FCF conversion rate: 11.996740236382323
Beneish M-score: -2.555067492349691 (Likely Safe)
ROE (%): 0.3132097672433855
Net margin (%): 1.267290109145849
Asset turnover: 0.21137037452718865
Equity multiplier (leverage): 1.1692708814984831
ROE archetype: Low Return
P/E z-score: 0.8218431360372277
FCF z-score: 4.009076866144344
Treasury beta 1y: -0.013169515394106417 (R-squared: 0.00010141055781290736)
Insider 90-day net shares: 51256 (net value USD: 19346.00)
Dividend increase streak (years): 0
ROIC (%): -2.646574225247046 (pretax: -4.0716526542262255)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 40.932642487046635, P/B 5.181347150259067, ROIC 76.68393782383419, revenue growth 1y 15.025906735751295, 6m momentum 62.69430051813472
Sector percentiles: P/E 36.43113159242192, 6m momentum 61.136712749615974
Industry median P/E: 0.3265277733522184; industry median ROIC: 6.830432455396816
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.06410458318693585
Base cash flow: -36065.28189910983
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MATV (Basic Materials — Specialty Chemicals, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 8.12
Market cap: 447553504 (USD: 447553504)
P/E ratio: 6.1063829787234045
P/B ratio: 1.0047873281388946
Debt to equity: 2.3266999999999998
Current ratio: 2.26
Interest coverage ratio: 0.49142857142857144
Buffett classification: The Gruesome
Analyst consensus upside (%): 143.90243902439025
Rule of 40 score: 1.5821280203811965
Altman Z-score: 0.493520928516355 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 0.8382883321961205, earnings yield % 0.5873701196263666, rank 2515
Dividend yield (%): 1.3182781382044548
Buyback yield (%): 0.4468739451540525
Debt paydown yield (%): -3.3515545886553935
Total shareholder yield (%): -1.5864025052968862 (Minimal or Negative)
Momentum (%): 1m 0.6195786864931714, 3m -15.854922279792758, 6m -34.88372093023257, 12m 12.309820193637604, composite -13.04012864953818 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 7, recommendation: Neutral
Revenue growth 1y (%): -1.0726072607260773
Revenue deceleration: no
Accrual ratio: -0.0021045933974500157
FCF conversion rate: 0.6324786324786325
Beneish M-score: -2.3598667229931243 (Likely Safe)
ROE (%): -2.4098867147270853
Net margin (%): -2.4395329441201
Asset turnover: 0.23473557986442503
Equity multiplier (leverage): 4.208341915550978
ROE archetype: Low Return
FCF z-score: 4.598500520288439
Treasury beta 1y: 0.0006112043830026687 (R-squared: 1.7270743248489717e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 2.4990656700480516 (pretax: 3.163374265883609)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 49.76744186046512, P/B 32.55813953488372, ROIC 66.27906976744185, revenue growth 1y 34.418604651162795, 6m momentum 81.16279069767441
Sector percentiles: P/E 22.987229317046083, 6m momentum 59.57801221543587
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06820396869210174
Base cash flow: -236400000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MAXHEALTH.NS (Healthcare — Medical Care Facilities, India)
Report date: 2026-03-31 (annual)
Stock price: 11.15194054500413
Market cap: 1051492614144 (USD: 11143414732.344213)
P/E ratio: 0.6847935189884967
P/B ratio: 8.660812434190493
Debt to equity: 0.3237
Current ratio: 0.89
Interest coverage ratio: 8.730189732142856
Return on net tangible assets (%): 8.871624558486548
Buffett classification: The Gruesome
Analyst consensus upside (%): 11470.06877023496
Rule of 40 score: 9.125758539739014
Altman Z-score: 10.90679569921569 (Safe Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 6.504869131576221, earnings yield % 0.004745749188439105, rank 2278
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -1.6983365987985246, 3m 5.20023703079686, 6m 3.1760717332139228, 12m -23.84083602036463, composite -4.71624727859654 (Strong Downtrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 4, short score 2, recommendation: Neutral
Revenue growth 1y (%): 7.904424214360284
Net income growth 1y (%): 21.536354092416964
Revenue CAGR 3y (%): 16.82156569316082
Net income CAGR 3y (%): 4.381265728640016
FCF CAGR 3y (%): -48.51340649195851
Revenue deceleration: yes
Revenue growth consistency score: 9.503433720374167
Accrual ratio: 0.07606357157335074
FCF conversion rate: 0.10315374962735978
Beneish M-score: -2.1944013879339166 (Likely Safe)
ROE (%): 13.67553001320328
Net margin (%): 17.535982921257613
Asset turnover: 0.48364711702554575
Equity multiplier (leverage): 1.6124470045917374
ROE archetype: Standard Business
P/E z-score: 4.388415984774518
FCF z-score: 4.388415984774516
Treasury beta 1y: 0.000701331283631663 (R-squared: 0.00011807752521502898)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 1
ROIC (%): 11.921118082063659 (pretax: 13.848203379028309)
Incremental ROIC 3y (%): 11.962432195082217 (pretax: 12.123260379118546)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 24.285714285714285, P/B 66.19047619047619, ROIC 22.857142857142858, revenue growth 1y 29.04761904761905, 6m momentum 31.428571428571427
Sector percentiles: P/E 11.568767908309455, 6m momentum 24.92836676217765
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.051300672584198286
Base cash flow: 44559135.226790994
DCF price per share: base 0.04546106960557418, conservative 0.02044700913976894, aggressive 0.09976748679516487
Financial scorecard for MAYURUNIQ.NS (Consumer Cyclical — Textile Manufacturing, India)
Report date: 2026-03-31 (annual)
Stock price: 8.140483071841453
Market cap: 34268893184 (USD: 363171822.63671046)
P/E ratio: 0.11808383108807247
P/B ratio: 1.888351111119954
Debt to equity: 0.0069
Current ratio: 7.46
Interest coverage ratio: 147.25554041454492
Return on net tangible assets (%): 17.49796532822137
Buffett classification: The Great
Analyst consensus upside (%): 17155.38586022049
Rule of 40 score: 10.867517693750903
Altman Z-score: 16.996544689501636 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 8.321394282928743, earnings yield % 0.026155258379942675, rank 1666
Dividend yield (%): 0.6334316046756627
Buyback yield (%): 0
Debt paydown yield (%): 0.06373511217593852
Total shareholder yield (%): 0.6971667168516013 (Low Return)
Momentum (%): 1m -3.5764820138299327, 3m 36.62075111743186, 6m 48.81553959425046, 12m 18.96178093248002, composite 36.270176363147534 (Moderate Uptrend)
Lynch category: Fast Grower (confidence: High)
Screener: long score 10, short score 0, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): -1.1018549031795333
Net income growth 1y (%): 29.82205891259786
Revenue deceleration: no
Beneish M-score: 0.9491137791800102 (Strong Manipulation Signal)
ROE (%): 5.248081349119626
Net margin (%): 21.74323891749513
Asset turnover: 0.2166073206574431
Equity multiplier (leverage): 1.1143027183628453
ROE archetype: Standard Business
P/E z-score: 4.227426477028641
FCF z-score: 4.227426477028647
Treasury beta 1y: -0.041929642349056995 (R-squared: 0.001328116816436969)
Insider 90-day net shares: 79024 (net value USD: 429353.00)
Dividend increase streak (years): 2
ROIC (%): 19.175383852826304 (pretax: 25.90009916338697)
Incremental ROIC 3y (%): 46.63584027308379 (pretax: 72.50493368146027)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 27.027027027027028, P/B 64.1891891891892, ROIC 4.72972972972973, revenue growth 1y 27.027027027027028, 6m momentum 6.756756756756757
Sector percentiles: P/E 15.820584144645341, 6m momentum 4.624478442280946
Industry median P/E: 0.18251138762789332; industry median ROIC: 4.332358383927475
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.0667015880430181
Base cash flow: 20996195.42178889
DCF price per share: base 0.08801966361030625, conservative 0.07279481593928089, aggressive 0.1084197720566612
Financial scorecard for MDLZ (Consumer Defensive — Confectioners, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 60.52
Market cap: 77686489088 (USD: 77686489088)
P/E ratio: 85.31343283582089
P/B ratio: 2.843490180768873
Debt to equity: 0.8379000000000001
Current ratio: 0.54
Interest coverage ratio: 5.8108108108108105
Return on net tangible assets (%): -5.036370703537121
Buffett classification: The Great
Analyst consensus upside (%): 17.687193841847446
Rule of 40 score: -2.7134146341463414
Altman Z-score: 1.7438209612927889 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 160.44776119402985, earnings yield % 0.8789997428656737, rank 553
Dividend yield (%): 0.8289729753014116
Buyback yield (%): 0
Debt paydown yield (%): 0.2342749712808337
Total shareholder yield (%): 1.0632479465822453 (Low Return)
Momentum (%): 1m -1.1595623060591111, 3m 5.933835112900403, 6m 5.398815743643333, 12m -10.763786493659675, composite 0.5385843954133319 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 6, recommendation: Neutral
Revenue growth 1y (%): 8.235799420165367
Net income growth 1y (%): 38.574938574938564
Revenue deceleration: no
Accrual ratio: 0.00573596336837086
FCF conversion rate: 0.274822695035461
Beneish M-score: -2.342345116001002 (Likely Safe)
ROE (%): 2.182029209788181
Net margin (%): 5.595238095238096
Asset turnover: 0.14136555196376105
Equity multiplier (leverage): 2.7586613792436405
ROE archetype: Low Return
P/E z-score: 4.497129180297657
FCF z-score: 4.497129180297651
Treasury beta 1y: -0.00015891314363087851 (R-squared: 8.810617432737315e-06)
Insider 90-day net shares: -64 (net value USD: -3934.00)
Dividend increase streak (years): 0
ROIC (%): 5.882751242500982 (pretax: 7.943822690366469)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 69.84126984126983, P/B 58.730158730158735, ROIC 38.095238095238095, revenue growth 1y 11.11111111111111, 6m momentum 23.809523809523807
Sector percentiles: P/E 61.69442433019551, 6m momentum 22.302679217958
Industry median P/E: 0.15703919494997043; industry median ROIC: 5.572919474291149
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.057518146175424834
Base cash flow: 3815000000
DCF price per share: base 121.23301073821482, conservative 76.10856076052461, aggressive 194.25370822867887
Financial scorecard for MDWD (Healthcare — Biotechnology, Israel)
Report date: 2026-03-31 (quarterly)
Stock price: 14.23
Market cap: 182887584 (USD: 182887584)
P/B ratio: 15.79502828472105
Debt to equity: 0.1962
Current ratio: 2.41
Return on net tangible assets (%): -10.61198860068589
Buffett classification: The Gruesome
Analyst consensus upside (%): 87.2749844816884
Rule of 40 score: -645.4453794819566
Altman Z-score: 9.139934084644281 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.004372617642078671
Total shareholder yield (%): -0.004372617642078671 (Minimal or Negative)
Momentum (%): 1m -4.175084175084169, 3m -14.892344497607645, 6m -19.604519774011294, 12m -31.78331735378715, composite -21.10266201192028 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): -56.45033525900558
Revenue deceleration: no
Revenue growth consistency score: 4.847558058737323
Accrual ratio: 0.06785981992776886
FCF conversion rate: 2.904471544715447
Beneish M-score: -2.37344965598755 (Likely Safe)
ROE (%): -6.9638585373876305
Net margin (%): -200.135593220339
Asset turnover: 0.017803848166748324
Equity multiplier (leverage): 1.954392222083005
ROE archetype: Low Return
Treasury beta 1y: 0.0016454696814772831 (R-squared: 0.00029317261477152293)
Insider 90-day net shares: 9687 (net value USD: 136047.00)
Dividend increase streak (years): 0
Incremental ROIC 3y (%): -77.8007482300859 (pretax: -98.48195978491887)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 61.01083032490975, ROIC , revenue growth 1y 25.180505415162457, 6m momentum 43.411552346570396
Sector percentiles: P/E , 6m momentum 49.96418338108882
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05508794708654551
Base cash flow: -8655345.911949685
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MEC.AX (Financial Services — Asset Management, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.8819444444444445
Market cap: 38347148 (USD: 25063495.424836602)
P/E ratio: 11.655773420479305
P/B ratio: 0.7783910721951484
Debt to equity: 0.023955162789523296
Return on net tangible assets (%): 13.116248672675152
Buffett classification: The Gruesome
Rule of 40 score: 8098.773701509001
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 13.994005499444182
Debt paydown yield (%): -2.592554210289641
Total shareholder yield (%): 11.40145128915454 (High Return)
Momentum (%): 1m -5.969158496732026, 3m 2.893518518518521, 6m 11.003352490421472, 12m 17.85275319567357, composite 13.077006031563059 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 5, short score 1, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.04058688730386803
FCF conversion rate: 0.6768015194472532
Beneish M-score: 65.86246828971599 (Strong Manipulation Signal)
ROE (%): 13.012486738854115
Net margin (%): 67.06101557912454
Asset turnover: 0.18726055624814839
Equity multiplier (leverage): 1.0362006602584701
ROE archetype: Standard Business
P/E z-score: 4.637015477686147
FCF z-score: 4.1397854588480545
Treasury beta 1y: 0.0034778067257414834 (R-squared: 0.003480360822165248)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 43.20875113947128, P/B 29.717411121239746, ROIC , revenue growth 1y , 6m momentum 14.129443938012761
Sector percentiles: P/E 36.00620796689084, 6m momentum 20.82255561303673
Industry median P/E: 7.917582417582417; industry median ROIC: 1.6915626385800535
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.10106317993632424
Base cash flow: 3558225.4901960786
DCF price per share: base 0.8326949667151917, conservative 0.7497600567897231, aggressive 0.929759350204458
Financial scorecard for MEDICAMEQ.NS (Healthcare — Drug Manufacturers - Specialty & Generic, India)
Report date: 2026-03-31 (annual)
Stock price: 2.496387283236994
Market cap: 3280166912 (USD: 34762260.61890632)
P/E ratio: 0.32586200203893595
P/B ratio: 1.0942319048343492
Debt to equity: 0.1734
Current ratio: 2.55
Interest coverage ratio: 3.5365414307771488
Return on net tangible assets (%): 4.450204088757517
Buffett classification: The Good
Rule of 40 score: -8.892576091199038
Altman Z-score: 2.6748342927545905 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0.41348505621411497
Buyback yield (%): 0
Debt paydown yield (%): -3.209273835316906
Total shareholder yield (%): -2.795788779102791 (Minimal or Negative)
Momentum (%): 1m 3.57721953726988, 3m -8.819759673432625, 6m -34.85272348491401, 12m -44.85378879329201, composite -30.14361410977901 (Strong Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): 85.65507776089203
Net income growth 1y (%): 66.84590930113919
Revenue deceleration: no
Revenue growth consistency score: 61.05821590204872
Beneish M-score: 3.3333946636949285 (Strong Manipulation Signal)
ROE (%): 3.837430415324241
Net margin (%): 4.953438266832584
Asset turnover: 0.5652355574994533
Equity multiplier (leverage): 1.3705796655719624
ROE archetype: Low Return
P/E z-score: 4.992556870326694
Treasury beta 1y: 0.0005140706553055155 (R-squared: 2.601261715472081e-05)
Insider 90-day net shares: -100000 (net value USD: )
Dividend increase streak (years): 0
ROIC (%): 3.461690300153447 (pretax: 4.234849662443242)
Incremental ROIC 3y (%): -13.491934114277868 (pretax: -14.571968285843303)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 19.06158357771261, P/B 26.97947214076246, ROIC 50.146627565982406, revenue growth 1y 2.6392961876832843, 6m momentum 75.65982404692082
Sector percentiles: P/E 8.667621776504298, 6m momentum 61.38968481375359
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08096736733548192
Base cash flow: 1296852.4798643494
DCF price per share: base 0.0227659233010074, conservative 0.016157062484152673, aggressive 0.03232260431567399
Financial scorecard for MEDICO.NS (Healthcare — Drug Manufacturers - Specialty & Generic, India)
Report date: 2026-03-31 (annual)
Stock price: 0.3921345995045417
Market cap: 3152562176 (USD: 33409942.518016107)
P/E ratio: 0.2187611016584709
P/B ratio: 3.5859913795412304
Debt to equity: 0.2544
Current ratio: 1.66
Interest coverage ratio: 7.713225931462104
Return on net tangible assets (%): 15.622212118279752
Buffett classification: The Good
Rule of 40 score: 24.618186427031034
Altman Z-score: 4.47340082222628 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.9480635525570937
Total shareholder yield (%): -0.9480635525570937 (Minimal or Negative)
Momentum (%): 1m -9.078267525353754, 3m -9.682361332911354, 6m -32.549607494578545, 12m -19.54303159061409, composite -17.913869600241878 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 2, recommendation: Neutral
Revenue growth 1y (%): 23.947327761858084
Net income growth 1y (%): 17.795134509575504
Revenue CAGR 3y (%): 9.041322937117346
Net income CAGR 3y (%): 16.36808011181159
FCF CAGR 3y (%): -8.546906474532056
Revenue deceleration: no
Revenue growth consistency score: 12.518703157403408
Accrual ratio: 0.08216068599207259
FCF conversion rate: 0.10556453580578261
Beneish M-score: -2.030872434329857 (Likely Safe)
ROE (%): 7.759706920880562
Net margin (%): 10.309517899862165
Asset turnover: 0.3703160231885494
Equity multiplier (leverage): 2.0325182677593094
ROE archetype: Standard Business
P/E z-score: 3.9698792424821376
FCF z-score: 3.268455622861063
Treasury beta 1y: 0.058679536777955725 (R-squared: 0.0018170536072397798)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 11.12814535621338 (pretax: 15.323430361341892)
Incremental ROIC 3y (%): 13.930228735515145 (pretax: 18.867537035754918)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 12.609970674486803, P/B 62.17008797653959, ROIC 25.219941348973606, revenue growth 1y 13.78299120234604, 6m momentum 73.90029325513197
Sector percentiles: P/E 6.912607449856734, 6m momentum 60.10028653295129
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07989252049868764
Base cash flow: 1248950.8266214496
DCF price per share: base 0.004082652231649174, conservative 0.0026523061716250953, aggressive 0.006320919298756978
Financial scorecard for MGL.NS (Utilities — Utilities - Regulated Gas, India)
Report date: 2026-03-31 (annual)
Stock price: 11.116845582163501
Market cap: 106383663104 (USD: 1127423305.4684188)
P/E ratio: 0.11489529220596263
P/B ratio: 1.4162664196694212
Debt to equity: 0.0346
Current ratio: 0.94
Interest coverage ratio: 49.652194656488554
Return on net tangible assets (%): 2.9363204804948455
Buffett classification: The Gruesome
Analyst consensus upside (%): 13188.1008300097
Rule of 40 score: 3.958347268091873
Altman Z-score: 2.7821238145248315 (Grey Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -11.52998641218043, 3m -7.427656705976466, 6m -4.49728544057551, 12m -31.131974969425002, composite -11.360529695073245 (Strong Downtrend)
Lynch category: Slow Grower (confidence: High)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): 2.907011420316663
Net income growth 1y (%): -26.70007578208339
Revenue CAGR 3y (%): 4.553196561169148
Net income CAGR 3y (%): -2.5183261363004528
FCF CAGR 3y (%): -33.478083860180085
Revenue deceleration: yes
Revenue growth consistency score: 7.519384748451719
Accrual ratio: 0.08334590642503045
FCF conversion rate: 0.10306251040254892
Beneish M-score: -2.3128535893291775 (Likely Safe)
ROE (%): 2.017203827005444
Net margin (%): 6.3322043809848685
Asset turnover: 0.22848486603007198
Equity multiplier (leverage): 1.3942396209631474
ROE archetype: Low Return
P/E z-score: 4.135998078068698
FCF z-score: 4.1359980780686945
Treasury beta 1y: 0.014400613166160236 (R-squared: 0.00023287890939258443)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 14.337169204707697 (pretax: 19.35257725057321)
Incremental ROIC 3y (%): -2.5284631954125873 (pretax: -2.9068159586421585)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 19.047619047619047, P/B 53.96825396825397, ROIC 7.936507936507936, revenue growth 1y 22.22222222222222, 6m momentum 58.730158730158735
Sector percentiles: P/E 7.459677419354839, 6m momentum 50.806451612903224
Industry median P/E: 1.8681897338087734; industry median ROIC: 5.409697954401452
Sector median P/E: 8.380462724935732; sector median ROIC: 4.834251840514727
WACC: 0.08594638186590198
Base cash flow: 18734633.31920305
DCF price per share: base 0.044288324706317404, conservative 0.03759505555864191, aggressive 0.053081231523021286
Financial scorecard for MGRX (Healthcare — Health Information Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.52
Market cap: 8939076 (USD: 8939076)
P/B ratio: 0.4586591119384753
Debt to equity: 0.0218
Current ratio: 0.29
Interest coverage ratio: -11.29391832090024
Buffett classification: The Gruesome
Rule of 40 score: -3566.711369900862
Altman Z-score: 0.4823563249028948 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.15437837199281
Total shareholder yield (%): 0.15437837199281 (Low Return)
Momentum (%): 1m 44.44444444444445, 3m 23.80952380952382, 6m 1.960784313725492, 12m -70.28571428571428, composite -17.886087768440706 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 13, recommendation: Short
Revenue growth 1y (%): -37.91374672936527
Revenue deceleration: no
Accrual ratio: -0.13699282709115318
FCF conversion rate: 0.38533313782767153
Beneish M-score: -4.529131116788605 (Likely Safe)
ROE (%): -23.737055932558583
Net margin (%): -5014.648414476011
Asset turnover: 0.004444445026581926
Equity multiplier (leverage): 1.065047126705882
ROE archetype: Low Return
Treasury beta 1y: -0.01517936981844763 (R-squared: 0.001291477645622633)
Insider 90-day net shares: -143333 (net value USD: -174014.00)
Dividend increase streak (years): 0
ROIC (%): -107.93089628108577 (pretax: -136.6213876975769)
Incremental ROIC 3y (%): -98.70880616578296 (pretax: -124.94785590605437)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 6.315789473684211, ROIC 55.78947368421052, revenue growth 1y 43.684210526315795, 6m momentum 20
Sector percentiles: P/E , 6m momentum 26.110315186246417
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -18918791
DCF price per share: base 0, conservative 0, aggressive 0